Federal health agencies were ordered to pause all communications this week, but these Washington health organizations are still running.

Dr. Dorothy Fink, the acting secretary for the Department of Health and Human Services under President Donald Trump, has instructed the heads of every federal health agency to stop public communication.

The administration of U.S. President Donald Trump has instructed federal health agencies to pause all external communications, such as health advisories, weekly scientific reports, updates to websites and social media posts,

Amid a deluge of executive actions, the Trump administration has directed federal health agencies to pause external communications, such as regular scientific reports, updates to websites and health advisories,

Current laws and regulations are not enough to protect Americans from the risks of compounded versions of popular weight loss drugs, especially those bought online, outgoing U.S. Food and Drug Administration Commissioner Robert Califf said on Thursday.

Many agencies in the U.S. have been tracking the H5N1 bird flu outbreak, which has been increasingly spreading.

The new Trump administration could put a stop to pending litigation on the abortion pill mifepristone and other federal abortion policies through changes at the Department of Health and Human Services, according to a top anti-abortion lawyer involved in several pending cases.

WASHINGTON -- The US Food and Drug Administration is proposing that nutrition information be placed on the front of packaged foods to provide at-a-glance information about saturated fat ...

The U.S. Department of Health and Human Services has paused public communications until Feb. 1 as Trump appointees take control of health agencies.

Some members of President-elect Donald Trump’s inner circle are gearing up to battle “Big Food" and reform Americans' diet.

The Trump administration has put a freeze on many federal health agency communications with the public through at least the end of the month.

Weight loss drugs like Ozempic and Wegovy have been tied in a large, national study to a drop in the risk of developing dozens of health conditions. But the semaglutide-like drugs also appear to increase the risk of many others.